CCS
SRGA

Crosspoint Capital Strategies’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Crosspoint Capital Strategies’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-150
Closed -$18K – 655
2014
Q1 		$18K Buy
+150
New +$16.2K 0.01% 391

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Crosspoint Capital Strategies's SRGA Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2014, closing a stake of 150 shares — an estimated $18K sold.

Crosspoint Capital Strategies first reported a position in SRGA in Q1 2014 and held it in 1 quarter. The position peaked at $18K in Q1 2014. 95 funds tracked by Wall St. Rank hold SRGA as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 150 Surgalign Holdings, Inc. Common Stock shares in Q2 2014, an estimated $18K.
  • Crosspoint Capital Strategies first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Surgalign Holdings, Inc. Common Stock position peaked at $18K in Q1 2014.
  • 95 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.